Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430583 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness
A Phase 3 study, sponsored by Mezzion Pharma Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 88
- Enrollment target
NCT03430583 is a Phase 3 study that has completed, run by Mezzion Pharma Co.. The registered enrollment target is 88 participants.
The verdict
NCT03430583, a Phase 3 study, has completed, sponsored by Mezzion Pharma Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 88 participants
- Enrollment target
Study Summary
A study to evaluate the efficacy of MZ101 therapy in reducing liver stiffness.
Interventions
- DRUG Udenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2020-09-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430583
The ClinicalTrials.gov registry entry for NCT03430583 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mezzion Pharma Co., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Udenafil is the first listed.
NCT03430583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03430583 about?
NCT03430583 is a clinical study titled "Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness". A study to evaluate the efficacy of MZ101 therapy in reducing liver stiffness.
What is the current status of trial NCT03430583?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 88 participants. The study started on 2018-02-20. Estimated completion is 2020-09-16.
What interventions are being tested in trial NCT03430583?
The interventions under investigation include: Udenafil (DRUG).
Who is sponsoring clinical trial NCT03430583?
This trial is sponsored by Mezzion Pharma Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.